Paul B Chapman

Sloan-Kettering Institute For Cancer Res

$2,261,706

Attributed

$2,261,706

Total exposure

Grants

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $653.4K · FY2005–07

$1M$750K$500K$250K$0

'05

'06

'07

Funding mix

By agency

NIH$2,261,706 · 3

By mechanism

R01$1,112,778 · 1

R21$724,068 · 1

K24$424,860 · 1

Top collaborators

No co-investigators on record.

Most similar at Sloan-Kettering Institute For Cancer Res

Same institution · by research overlap

Neal Rosen$21,048,001
Pier Paolo Pandolfi$54,825,346
David R Spriggs$13,987,182
Harold E Varmus$14,554,892
Robert I Benezra$12,794,451

Others in their field

Top investigators on “Gangliosides”

Wayne Lencer · Children'S Hospital Boston$13,275,957
Kazim A Sheikh · University Of Texas Hlth Sci Ctr Houston$9,699,295
Ronald L Schnaar · Johns Hopkins University$9,656,139
Jennifer J Kohler · Ut Southwestern Medical Center$6,907,121
Robert K. Yu · Medical College Of Georgia (Mcg)$6,779,656
Stephan Ladisch · Children'S Research Institute$6,279,972

Research focus

GangliosidesTumor AntigensClinical TrialsHuman SubjectAntiidiotype AntibodySmall Cell Lung CancerOncogenesPancreas NeoplasmsNeoplasm /Cancer VaccineHuman Therapy EvaluationGene MutationAntibody FormationBacillus Calmette Guerin VaccineMonoclonal AntibodyImmunoconjugatesNeoplasm /Cancer ImmunotherapyDifferentiation AntigensVaccine DevelopmentImmunizationClinical ResearchLaboratory MouseMelanomaT Cell ReceptorNeoplasm /Cancer Immunology